Genomic risk classifier performance in PET-guided post-prostatectomy patients: Secondary analysis of a randomized trial.
Clinical outcomes of patients with grade group 1 prostate cancer with extraprostatic extension: Results from up to 25 years of follow-up.
Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results